Citigroup’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06B | Buy |
|
|||||
|
2025
Q1 | $850M | Sell |
|
|||||
|
2024
Q4 | $1B | Buy |
|
|||||
|
2024
Q3 | $766M | Buy |
|
|||||
|
2024
Q2 | $673M | Sell |
|
|||||
|
2024
Q1 | $837M | Buy |
|
|||||
|
2023
Q4 | $367M | Sell |
|
|||||
|
2023
Q3 | $410M | Buy |
|
|||||
|
2023
Q2 | $404M | Sell |
|
|||||
|
2023
Q1 | $478M | Sell |
|
|||||
|
2022
Q4 | $622M | Buy |
|
|||||
|
2022
Q3 | $390M | Sell |
|
|||||
|
2022
Q2 | $375M | Buy |
|
|||||
|
2022
Q1 | $363M | Buy |
|
|||||
|
2021
Q4 | $408M | Buy |
|
|||||
|
2021
Q3 | $332M | Sell |
|
|||||
|
2021
Q2 | $774M | Sell |
|
|||||
|
2021
Q1 | $854M | Buy |
|
|||||
|
2020
Q4 | $848M | Sell |
|
|||||
|
2020
Q3 | $887M | Buy |
|
|||||
|
2020
Q2 | $888M | Sell |
|
|||||
|
2020
Q1 | $811M | Buy |
|
|||||
|
2019
Q4 | $781M | Sell |
|
|||||
|
2019
Q3 | $775M | Buy |
|
|||||
|
2019
Q2 | $720M | Sell |
|
|||||
|
2019
Q1 | $765M | Buy |
|
|||||
|
2018
Q4 | $571M | Buy |
|
|||||
|
2018
Q3 | $542M | Sell |
|
|||||
|
2018
Q2 | $540M | Sell |
|
|||||
|
2018
Q1 | $570M | Buy |
|
|||||
|
2017
Q4 | $535M | Buy |
|
|||||
|
2017
Q3 | $425M | Sell |
|
|||||
|
2017
Q2 | $521M | Buy |
|
|||||
|
2017
Q1 | $335M | Buy |
|
|||||
|
2016
Q4 | $226M | Sell |
|
|||||
|
2016
Q3 | $549M | Buy |
|
|||||
|
2016
Q2 | $312M | Buy |
|
|||||
|
2016
Q1 | $157M | Buy |
|
|||||
|
2015
Q4 | $195M | Sell |
|
|||||
|
2015
Q3 | $177M | Sell |
|
|||||
|
2015
Q2 | $318M | Buy |
|
|||||
|
2015
Q1 | $217M | Buy |
|
|||||
|
2014
Q4 | $85.5M | Buy |
|
|||||
|
2014
Q3 | $56.5M | Sell |
|
|||||
|
2014
Q2 | $86M | Buy |
|
|||||
|
2014
Q1 | $76.6M | Sell |
|
|||||
|
2013
Q4 | $72.5M | Buy |
|
|||||
|
2013
Q3 | $40.4M | Sell |
|
|||||
|
2013
Q2 | $89.6M | Buy |
|